EP3938368
COMPOUND FORM HAVING ENHANCED BIOAVAILABILITY AND FORMULATIONS THEREOF
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
9.3.2020EP published:
7.6.2023EP application number:
20717027.5
EPO information:
European Patent Register
Max expiry date:
8.3.2040
Title in English:
COMPOUND FORM HAVING ENHANCED BIOAVAILABILITY AND FORMULATIONS THEREOFLanguage of the patent:
English
Timeline
Today
9.3.2020EP application
7.6.2023EP Publication
Owner
Name:
PTC Therapeutics, Inc.Address:
100 Corporate Court,, South Plainfield, NJ 07080, US
Inventor
Name:
UDDIN, Akm, NasirAddress:
Somerset, NJ 08873, US
Name:
DALI, Mandar, VasantAddress:
Bridgewater, NY 08807, US
Name:
VAZE, Onkar, ShripadAddress:
Fords, NJ 08863, US
Priority
Number:
201962816402 PDate:
11.3.2019Country:
US
Classification
Categories:
C07D 487/04